Experience
Abbott Laboratories
Teva Pharmaceuticals USA, Inc.
Member of team that represented Abbott Laboratories in district court Hatch-Waxman litigation related to Zemplar® (paricalcitol) for secondary hyperparathyroidism.
Abbott Laboratories v. Teva Pharmaceuticals USA, Inc. , 1:08-cv-06659, N.D. Ill., Judge Kocoras
Novartis Pharmaceuticals Corporation et al. v. Fresenius Kabi USA, LLC et al.
Novartis Pharmaceuticals Corporation et al.
Uniloc USA, Inc. et al. v. Motorola Mobility LLC et al.
Motorola Mobility LLC et al.
Rokiot USA, LLC v. BOSCH Software Innovation Corp., et al.
Bosch Software Innovation Corp.
Medtronic Vascular Inc. v. Abbott Vascular, Inc.
Abbott Vascular, Inc.
Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al.
Biogen MA Inc. et al.
Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al.
Duchesnay Inc.
Regenxbio, Inc. et al. v. Sarepta Therapeutics, Inc. et al.
Sarepta Therapeutics, Inc. et al.
Eli Lilly and Company v. Actavis Labs. UT Inc.
Eli Lilly and Company
Grünenthal GmbH et al. v. Alvogen Pine Brook, Inc. et al.
Grünenthal GmbH et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.